Henk Rietbergen

873 total citations
15 papers, 638 citations indexed

About

Henk Rietbergen is a scholar working on Anesthesiology and Pain Medicine, Surgery and Developmental Neuroscience. According to data from OpenAlex, Henk Rietbergen has authored 15 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Anesthesiology and Pain Medicine, 9 papers in Surgery and 5 papers in Developmental Neuroscience. Recurrent topics in Henk Rietbergen's work include Anesthesia and Sedative Agents (13 papers), Anesthesia and Pain Management (9 papers) and Anesthesia and Neurotoxicity Research (5 papers). Henk Rietbergen is often cited by papers focused on Anesthesia and Sedative Agents (13 papers), Anesthesia and Pain Management (9 papers) and Anesthesia and Neurotoxicity Research (5 papers). Henk Rietbergen collaborates with scholars based in Austria, Belgium and Netherlands. Henk Rietbergen's co-authors include Bernard Vanacker, Karel M. Vermeyen, Vera Saldien, H. J. Sparr, Karin S. Khuenl-Brady, Corinna Velik‐Salchner, José Antonio Álvarez Gómez, Johannes H. Proost, M. Wattwil and M. E. Prins and has published in prestigious journals such as Anesthesiology, Anesthesia & Analgesia and British Journal of Anaesthesia.

In The Last Decade

Henk Rietbergen

15 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henk Rietbergen Austria 10 587 314 289 202 145 15 638
M. E. Prins Austria 7 730 1.2× 370 1.2× 363 1.3× 238 1.2× 186 1.3× 11 800
Lynn Graham Henson United States 7 419 0.7× 235 0.7× 241 0.8× 61 0.3× 79 0.5× 8 509
J. J. Krintel Denmark 7 451 0.8× 254 0.8× 144 0.5× 143 0.7× 176 1.2× 11 567
Frank Schippers United States 12 684 1.2× 287 0.9× 242 0.8× 370 1.8× 133 0.9× 15 745
G. Gehan France 4 351 0.6× 203 0.6× 140 0.5× 107 0.5× 129 0.9× 6 391
Allison Martinez Australia 10 292 0.5× 122 0.4× 130 0.4× 109 0.5× 53 0.4× 18 403
J.M. Hunter United Kingdom 10 295 0.5× 233 0.7× 89 0.3× 86 0.4× 98 0.7× 18 442
Toni Magorian United States 6 418 0.7× 209 0.7× 78 0.3× 98 0.5× 105 0.7× 6 481
K. Norrild Denmark 5 247 0.4× 145 0.5× 123 0.4× 76 0.4× 109 0.8× 6 327
Charles T. Gonsowski United States 8 408 0.7× 88 0.3× 271 0.9× 113 0.6× 134 0.9× 9 551

Countries citing papers authored by Henk Rietbergen

Since Specialization
Citations

This map shows the geographic impact of Henk Rietbergen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henk Rietbergen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henk Rietbergen more than expected).

Fields of papers citing papers by Henk Rietbergen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henk Rietbergen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henk Rietbergen. The network helps show where Henk Rietbergen may publish in the future.

Co-authorship network of co-authors of Henk Rietbergen

This figure shows the co-authorship network connecting the top 25 collaborators of Henk Rietbergen. A scholar is included among the top collaborators of Henk Rietbergen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henk Rietbergen. Henk Rietbergen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Monk, Terri G., Henk Rietbergen, Tiffany Woo, & Hein Fennema. (2015). Use of Sugammadex in Patients With Obesity: A Pooled Analysis. American Journal of Therapeutics. 24(5). e507–e516. 12 indexed citations
2.
Rahe‐Meyer, Niels, Christian Berger, Mária Wittmann, et al.. (2015). Recovery from prolonged deep rocuronium-induced neuromuscular blockade. Der Anaesthesist. 64(7). 506–512. 17 indexed citations
3.
Xin-min, WU, Jin Liu, Bernard Vanacker, et al.. (2014). Rocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjects. BMC Anesthesiology. 14(1). 53–53. 30 indexed citations
4.
Hudson, Mark E., Henk Rietbergen, & Jacques E. Chelly. (2014). Sugammadex is effective in reversing rocuronium in the presence of antibiotics. BMC Anesthesiology. 14(1). 69–69. 1 indexed citations
5.
6.
Drobnik, Leon, H. J. Sparr, Sven‐Egron Thörn, et al.. (2010). A randomized simultaneous comparison of acceleromyography with a peripheral nerve stimulator for assessing reversal of rocuronium-induced neuromuscular blockade with sugammadex. European Journal of Anaesthesiology. 27(10). 866–873. 13 indexed citations
7.
Rex, Christopher, Stefanie Wagner, Claudia Spies, et al.. (2009). Reversal of Neuromuscular Blockade by Sugammadex after Continuous Infusion of Rocuronium in Patients Randomized to Sevoflurane or Propofol Maintenance Anesthesia. Anesthesiology. 111(1). 30–35. 35 indexed citations
8.
Khuenl-Brady, Karin S., et al.. (2009). Sugammadex Provides Faster Reversal of Vecuronium-Induced Neuromuscular Blockade Compared with Neostigmine: A Multicenter, Randomized, Controlled Trial. Anesthesia & Analgesia. 110(1). 64–73. 120 indexed citations
9.
Khuenl-Brady, Karin S., Henk Rietbergen, M. E. Prins, & R. K. Mirakhur. (2008). Reversal of shallow vecuronium-induced neuromuscular blockade is achieved more rapidly with sugammadex than with neostigmine: A pooled analysis of phase II and III clinical trials. European Journal of Anaesthesiology. 25(Sup 44). 138–138. 2 indexed citations
10.
11.
Sparr, H. J., Karel M. Vermeyen, Henk Rietbergen, et al.. (2007). Early Reversal of Profound Rocuronium-induced Neuromuscular Blockade by Sugammadex in a Randomized Multicenter Study: Efficacy, Safety, and Pharmacokinetics. Anesthesiology. 106(5). 935–943. 163 indexed citations
12.
Vanacker, Bernard, Karel M. Vermeyen, Michel Struys, et al.. (2007). Reversal of Rocuronium-Induced Neuromuscular Block with the Novel Drug Sugammadex Is Equally Effective Under Maintenance Anesthesia with Propofol or Sevoflurane. Anesthesia & Analgesia. 104(3). 563–568. 104 indexed citations
13.
Vanacker, Bernard, Karel M. Vermeyen, Michel Struys, et al.. (2005). Reversal by Org 25969 is not affected by sevoflurane compared with propofol. European Journal of Anaesthesiology. 22(Supplement 34). 119–119. 2 indexed citations
14.
Ramael, Steven, et al.. (2002). Preliminary Assessment of Org 25969 as a Reversal Agent for Rocuronium in Healthy Male Volunteers. Anesthesiology. 96(Sup 2). A1008–A1008. 5 indexed citations
15.
Blobner, Manfred, R. K. Mirakhur, J. Mark K. H. Wierda, et al.. (2000). Rapacuronium 2.0 or 2.5 mg kg −1 for rapid-sequence induction: comparison with succinylcholine 1.0 mg kg −1. British Journal of Anaesthesia. 85(5). 724–731. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. E. Prins Breakdown of academic impact, for papers by Lynn Graham Henson Breakdown of academic impact, for papers by J. J. Krintel Breakdown of academic impact, for papers by Frank Schippers Breakdown of academic impact, for papers by G. Gehan Breakdown of academic impact, for papers by Allison Martinez Breakdown of academic impact, for papers by J.M. Hunter Breakdown of academic impact, for papers by Toni Magorian Breakdown of academic impact, for papers by K. Norrild Breakdown of academic impact, for papers by Charles T. Gonsowski
Rankless by CCL
2026